With domestic drugmaker AstraZeneca among the companies leading the charge to produce COVID-19 vaccines, the U.K. was well positioned for a quick rollout.
But after a successful first few months of vaccinations, the campaign has slowed as AstraZeneca’s primary manufacturing partner, the Serum Institute of India, has been forced to withhold exports as India deals with a coronavirus wave.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,